Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

LeMaitre Vascular, Inc. - Common Stock (NQ:LMAT)

84.91 +0.14 (+0.16%)
Streaming Delayed Price Updated: 11:23 AM EDT, May 19, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 28,721
Open 83.60
Bid (Size) 84.70 (1)
Ask (Size) 85.10 (1)
Prev. Close 84.77
Today's Range 83.18 - 85.09
52wk Range 71.42 - 109.58
Shares Outstanding 22,263,235
Dividend Yield 0.94%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
LMAT Q1 Earnings Call: Sales Growth Outpaces Expectations, Margin Pressures Addressed
Medical device company LeMaitre Vascular (NASDAQ:LMAT) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 12% year on year to $59.87 million. The company expects next quarter’s revenue... 
Via StockStory
Topics World Trade
Exposures Tariff
1 Cash-Heavy Stock That Stand Out and 2 to Question
A cash-heavy balance sheet is often a sign of strength, but not always. Some companies avoid debt because they have weak business models, limited expansion opportunities, or inconsistent cash flow. 
Via StockStory

Performance

YTD
-7.2%
-7.2%
1 Month
+0.2%
+0.2%
3 Month
-15.7%
-15.7%
6 Month
-18.0%
-18.0%
1 Year
+6.9%
+6.9%

More News

Read More
Q1 Earnings Highs And Lows: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Why LeMaitre (LMAT) Shares Are Sliding Today
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Earnings Scheduled For May 1, 2025
Via Benzinga
Earnings Scheduled For February 27, 2025
Via Benzinga
LeMaitre’s (NASDAQ:LMAT) Q1: Beats On Revenue, Guides for Strong Full-Year Sales
Via StockStory
A Look at LeMaitre Vascular's Upcoming Earnings Report
Via Benzinga
Earnings To Watch: LeMaitre (LMAT) Reports Q1 Results Tomorrow
Via StockStory
Topics Artificial Intelligence World Trade
Exposures Artificial Intelligence Tariff
1 Profitable Stock with Impressive Fundamentals and 2 to Steer Clear Of
Via StockStory
Novocure Stock Earns 96 RS Rating
Via Investor's Business Daily
In-Depth Examination Of 4 Analyst Recommendations For LeMaitre Vascular
Via Benzinga
Q4 Earnings Highlights: LeMaitre (NASDAQ:LMAT) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
3 Healthcare Stocks Facing Headwinds
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Spotting Winners: Teleflex (NYSE:TFX) And Surgical Equipment & Consumables - Specialty Stocks In Q4
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Why LEMAITRE VASCULAR INC (NASDAQ:LMAT) qualifies as a quality stock.
Via Chartmill
2 Reasons to Avoid LMAT and 1 Stock to Buy Instead
Via StockStory
Topics Stocks Supply Chain
Exposures Supply Chain US Equities
Winners And Losers Of Q4: Integra LifeSciences (NASDAQ:IART) Vs The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
Q4 Earnings Review: Surgical Equipment & Consumables - Specialty Stocks Led by Intuitive Surgical (NASDAQ:ISRG)
Via StockStory
Topics Artificial Intelligence Economy
Exposures Artificial Intelligence Supply Chain
LeMaitre (NASDAQ:LMAT) Misses Q4 Sales Targets, Stock Drops 11%
Via StockStory
What To Expect From LeMaitre’s (LMAT) Q4 Earnings
Via StockStory
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Inari Medical Stock Gets RS Rating Upgrade
Via Investor's Business Daily
ResMed Is 80 And 80: Hits 80-Plus Relative Strength Rating After Rising 80% In A Year
Via Investor's Business Daily
Apple To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Friday
Via Benzinga

Frequently Asked Questions

Is LeMaitre Vascular, Inc. - Common Stock publicly traded?
Yes, LeMaitre Vascular, Inc. - Common Stock is publicly traded.
What exchange does LeMaitre Vascular, Inc. - Common Stock trade on?
LeMaitre Vascular, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for LeMaitre Vascular, Inc. - Common Stock?
The ticker symbol for LeMaitre Vascular, Inc. - Common Stock is LMAT on the Nasdaq Stock Market
What is the current price of LeMaitre Vascular, Inc. - Common Stock?
The current price of LeMaitre Vascular, Inc. - Common Stock is 84.91
When was LeMaitre Vascular, Inc. - Common Stock last traded?
The last trade of LeMaitre Vascular, Inc. - Common Stock was at 05/19/25 11:23 AM ET
What is the market capitalization of LeMaitre Vascular, Inc. - Common Stock?
The market capitalization of LeMaitre Vascular, Inc. - Common Stock is 1.89B
How many shares of LeMaitre Vascular, Inc. - Common Stock are outstanding?
LeMaitre Vascular, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.